Skip to content
value.today

AristaMD, Inc.

🇺🇸 La Jolla, California, USAHospitals and PhysiciansFounded 2013
Total raised
$54 M
15 rounds on record
Latest round
$10 M
Dec 2021
First round on record
Jul 2014
Today
Private
No later event on record

Funding rounds

15 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of AristaMD, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2023$17 MIssued in a merger or acquisition$10 to $50 million

AristaMD, Inc.: Private sale, Nov 2023

Investors in this round

27 investors had bought by the notice of Nov 17, 2023: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $20 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Ann Barnes · Director
  • Brant Heise · Director
  • Craig Cimini · Director
  • David Eichler · Director
  • John Kuelper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes up to i) $13,536,853 shares of Ser C Pref Stk (portion of which were issued as merger consideration) ii) $5,201,155 conv prom notes & iii) $1,443,267 int on conv prom notes that converted into shares of Ser C-1 Pref Stk.”
  • On a merger: “A portion of the securities covered hereby were issued in a financing and a portion were issued as merger consideration in connection with an acquisition by the Company.”

Signed by Brooke LeVasseur, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 17, 2023. Read the notice at the SEC.

equity, debt, optionsSEC
Dec 2021$10 MNo. 15$10 to $50 million

AristaMD, Inc.: Raise no. 15, Dec 2021

Investors in this round

7 investors had bought by the notice of Mar 7, 2022: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Ann Barnes · Director
  • Brant Heise · Director
  • Craig Cimini · Director
  • John Kuelper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed Mar 7, 2022. Read the notice at the SEC.

debt, optionsSEC
Mar 2020$22 MNo. 14$10 to $50 million

AristaMD, Inc.: Raise no. 14, Mar 2020

Investors in this round

7 investors had bought by the notice of Jul 21, 2020: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Brant Heise · Director
  • Craig Cimini · Director
  • John Kuelper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 21, 2020. Read the notice at the SEC.

equity, debt, optionsSEC
Feb 2020$1 MNo. 13Under $2 million

AristaMD, Inc.: Raise no. 13, Feb 2020

Investors in this round

1 investor had bought by the notice of Feb 28, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Michael Scarbrough · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed Feb 28, 2020. Read the notice at the SEC.

debt, optionsSEC
Jun 2019$2 MNo. 12Under $2 million

AristaMD, Inc.: Raise no. 12, Jun 2019

Investors in this round

1 investor had bought by the notice of Oct 4, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Michael Scarbrough · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed Oct 4, 2019. Read the notice at the SEC.

debt, optionsSEC
Mar 2019$2 MNo. 11Under $2 million

AristaMD, Inc.: Raise no. 11, Mar 2019

Investors in this round

1 investor had bought by the notice of May 28, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Michael Scarbrough · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed May 28, 2019. Read the notice at the SEC.

debt, optionsSEC
Dec 2018$1 MNo. 10Under $2 million

AristaMD, Inc.: Raise no. 10, Dec 2018

Investors in this round

1 investor had bought by the notice of Dec 17, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Michael Scarbrough · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed Dec 17, 2018. Read the notice at the SEC.

debt, optionsSEC
Oct 2018$1 MNo. 9Under $2 million

AristaMD, Inc.: Raise no. 9, Oct 2018

Investors in this round

1 investor had bought by the notice of Oct 25, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Michael Scarbrough · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed Oct 25, 2018. Read the notice at the SEC.

debt, optionsSEC
Jun 2018$1 MNo. 8Under $2 million

AristaMD, Inc.: Raise no. 8, Jun 2018

Investors in this round

1 investor had bought by the notice of Jul 10, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Michael Scarbrough · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed Jul 10, 2018. Read the notice at the SEC.

debt, optionsSEC
Dec 2017$3 MNo. 7$2 to $10 million

AristaMD, Inc.: Raise no. 7, Dec 2017

Investors in this round

1 investor had bought by the notice of Mar 30, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brooke LeVasseur · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Michael Scarborough · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brooke LeVasseur, Ceo. Source: SEC Form D, newest notice filed Mar 30, 2018. Read the notice at the SEC.

debt, optionsSEC
Sep 2017$1 MNo. 6Under $2 million

AristaMD, Inc.: Raise no. 6, Sep 2017

Investors in this round

1 investor had bought by the notice of Sep 18, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jay Lichter · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jay Lichter, Ceo. Source: SEC Form D, newest notice filed Sep 18, 2017. Read the notice at the SEC.

debt, optionsSEC
Jun 2017$1 MNo. 5Under $2 million

AristaMD, Inc.: Raise no. 5, Jun 2017

Investors in this round

1 investor had bought by the notice of Jul 12, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jay Lichter · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jay Lichter, Ceo. Source: SEC Form D, newest notice filed Jul 12, 2017. Read the notice at the SEC.

debt, optionsSEC
May 2016$5 MNo. 4$2 to $10 million

AristaMD, Inc.: Raise no. 4, May 2016

Investors in this round

2 investors had bought by the notice of Jun 1, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $7 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rebecca Cofinas · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Amount Sold includes amounts paid pursuant to conversion of indebtedness.”

Signed by Rebecca Cofinas, President & CEO. Source: SEC Form D, newest notice filed Jun 1, 2016. Read the notice at the SEC.

equitySEC
Mar 2016$1 MNo. 3Under $2 million

AristaMD, Inc.: Raise no. 3, Mar 2016

Investors in this round

2 investors had bought by the notice of Mar 23, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rebecca Cofinas · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Lesley Young · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rebecca Cofinas, President & CEO. Source: SEC Form D, newest notice filed Mar 23, 2016. Read the notice at the SEC.

debt, optionsSEC
Nov 2015$1 MNo. 2Under $2 million

AristaMD, Inc.: Raise no. 2, Nov 2015

Investors in this round

2 investors had bought by the notice of Dec 15, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rebecca Cofinas · Executive Officer, Director
  • Tighe Reardon · Executive Officer, Director
  • Jay Lichter · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rebecca Cofinas, President & CEO. Source: SEC Form D, newest notice filed Dec 15, 2015. Read the notice at the SEC.

debt, optionsSEC
Jul 2014$2 MNo. 1$2 to $10 million

AristaMD, Inc.: Raise no. 1, Jul 2014

Investors in this round

6 investors had bought by the notice of Aug 15, 2014: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Douglas Downs · Executive Officer, Director
  • Rebecca Cofinas · Executive Officer, Director
  • Jay Lichter · Director
  • Thomas Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes $575,998.42 of securities issued upon the conversion of convertible promissory notes.”

Signed by Rebecca Cofinas, President & CEO. Source: SEC Form D, newest notice filed Aug 15, 2014. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • AristaMD, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2023).

    SEC Form D · Nov 2023

  • The industry group it chose in its notices: Hospitals and Physicians.

    SEC Form D · Nov 2023

That is all the official record says: AristaMD, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of AristaMD, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 15 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by AristaMD, Inc.
NameRoleNamed in
Brooke LeVasseurExecutive officerNov 2023
Tighe ReardonExecutive officerMar 2022
Jay LichterExecutive officerSep 2017
Rebecca CofinasExecutive officerJun 2016
Douglas DownsExecutive officerAug 2014
Ann BarnesDirectorNov 2023
Brant HeiseDirectorNov 2023
Brooke LeVasseurDirectorNov 2023
Craig CiminiDirectorNov 2023
David EichlerDirectorNov 2023
John KuelperDirectorNov 2023
Tighe ReardonDirectorMar 2022
Jay LichterDirectorFeb 2020
Michael ScarbroughDirectorFeb 2020
Thomas CooperDirectorFeb 2020
Michael ScarboroughDirectorMar 2018
Rebecca CofinasDirectorJun 2016
Lesley YoungDirectorMar 2016
Douglas DownsDirectorAug 2014